Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A functional toll-like receptor 8 variant is associated with HIV disease restriction.
Oh DY, Taube S, Hamouda O, Kücherer C, Poggensee G, Jessen H, Eckert JK, Neumann K, Storek A, Pouliot M, Borgeat P, Oh N, Schreier E, Pruss A, Hattermann K, Schumann RR. Oh DY, et al. Among authors: poggensee g. J Infect Dis. 2008 Sep 1;198(5):701-9. doi: 10.1086/590431. J Infect Dis. 2008. PMID: 18605904
Comparison of the human immunodeficiency virus (HIV) type 1-specific immunoglobulin G capture enzyme-linked immunosorbent assay and the avidity index method for identification of recent HIV infections.
Loschen S, Bätzing-Feigenbaum J, Poggensee G, Cordes C, Hintsche B, Rausch M, Dupke S, Gohlke-Micknis S, Rödig J, Hamouda O, Kücherer C. Loschen S, et al. Among authors: poggensee g. J Clin Microbiol. 2008 Jan;46(1):341-5. doi: 10.1128/JCM.01055-07. Epub 2007 Oct 31. J Clin Microbiol. 2008. PMID: 17977990 Free PMC article.
Implications of and perspectives on HIV surveillance using a serological method to measure recent HIV infections in newly diagnosed individuals: results from a pilot study in Berlin, Germany, in 2005-2007.
Bätzing-Feigenbaum J, Loschen S, Gohlke-Micknis S, Hintsche B, Rausch M, Hillenbrand H, Cordes C, Poggensee G, Kücherer C, Hamouda O. Bätzing-Feigenbaum J, et al. Among authors: poggensee g. HIV Med. 2009 Apr;10(4):209-18. doi: 10.1111/j.1468-1293.2008.00672.x. Epub 2009 Jan 22. HIV Med. 2009. PMID: 19207597 Free article.
Patterns of transmitted HIV drug resistance in Europe vary by risk group.
Frentz D, van de Vijver D, Abecasis A, Albert J, Hamouda O, Jørgensen L, Kücherer C, Struck D, Schmit JC, Vercauteren J, Asjö B, Balotta C, Bergin C, Beshkov D, Camacho R, Clotet B, Griskevicius A, Grossman Z, Horban A, Kolupajeva T, Korn K, Kostrikis L, Linka KL, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Stanekova D, Stanojevic M, Vandamme AM, Boucher C, Wensing A; SPREAD Programme. Frentz D, et al. PLoS One. 2014 Apr 10;9(4):e94495. doi: 10.1371/journal.pone.0094495. eCollection 2014. PLoS One. 2014. PMID: 24721998 Free PMC article.
The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy.
Pillay D, Bhaskaran K, Jurriaans S, Prins M, Masquelier B, Dabis F, Gifford R, Nielsen C, Pedersen C, Balotta C, Rezza G, Ortiz M, de Mendoza C, Kücherer C, Poggensee G, Gill J, Porter K; CASCADE Virology Collaboration. Pillay D, et al. Among authors: poggensee g. AIDS. 2006 Jan 2;20(1):21-8. doi: 10.1097/01.aids.0000196172.35056.b7. AIDS. 2006. PMID: 16327315
Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.
Masquelier B, Bhaskaran K, Pillay D, Gifford R, Balestre E, Jørgensen LB, Pedersen C, van der Hoek L, Prins M, Balotta C, Longo B, Kücherer C, Poggensee G, Ortiz M, de Mendoza C, Gill J, Fleury H, Porter K; CASCADE Collaboration. Masquelier B, et al. Among authors: poggensee g. J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):505-11. doi: 10.1097/01.qai.0000186361.42834.61. J Acquir Immune Defic Syndr. 2005. PMID: 16284524
Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.
Frentz D, Van de Vijver DA, Abecasis AB, Albert J, Hamouda O, Jørgensen LB, Kücherer C, Struck D, Schmit JC, Vercauteren J, Åsjö B, Balotta C, Beshkov D, Camacho RJ, Clotet B, Coughlan S, Griskevicius A, Grossman Z, Horban A, Kolupajeva T, Korn K, Kostrikis LG, Liitsola K, Linka M, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Stanekova D, Stanojevic M, Van Wijngaerden E, Wensing AM, Boucher CA; SPREAD Programme. Frentz D, et al. BMC Infect Dis. 2014 Jul 21;14:407. doi: 10.1186/1471-2334-14-407. BMC Infect Dis. 2014. PMID: 25047543 Free PMC article. Clinical Trial.
94 results